- Report
- May 2025
- 50 Pages
Global
From €2424EUR$2,650USD£2,063GBP
The Meglutol market is a segment of the cardiovascular drugs market, which includes drugs used to treat conditions related to the heart and blood vessels. Meglutol is a type of drug used to treat high cholesterol, a condition that can lead to heart disease. It works by blocking the absorption of cholesterol in the intestines, reducing the amount of cholesterol in the blood. Meglutol is available in both generic and brand-name forms.
The Meglutol market is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Other companies in the market include GlaxoSmithKline, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more